Caplight Directory>Companies>Nuclivision-preview>Nuclivision


Nuclivision

Nuclivision

Private
BelgiumHealthcare & Life Scienceshttps://www.nuclivision.com/

Last Round

Seed

Apr 24, 2025

Total Funding Raised

$5.94M

Momentum Score

25 /100

Company Overview

Nuclivision is a healthtech company that develops an AI-powered software platform, Nuclarity, designed to improve PET (positron emission tomography) imaging.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

AI medical imagingPET scan enhancementnuclear medicine softwarelow-dose PETradiation dose reductionradiology AImedical image enhancementfast PET scansimage reconstructionPositron Emission TomographyPETPACS integrationclinical AI softwareimage denoisingoncology imagingneurodegenerative disease imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuclivision Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nuclivision Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Tomas Brants

Cofounder COO

Founding Team

Nuclivision Investors

Notable investors and investment history

InvestorRounds
LUMO LabsSeed
HERAN PartnersSeed
Imec.iStartSeed
View all Investors

Nuclivision Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nuclivision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nuclivision's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range21
Year Founded2022
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.